Altogether, these data suggest that increased levels of MINDIN alter the functionality of NHERF-1 by decreasing its expression and by triggering NHERF-1 mobilization from the plasma membrane to the cytoplasm in prostate adenocarcinoma cells. Here, SPON2 is linked to prostate adenocarcinoma.